All sponsors

Onconic Therapeutics Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING2
READOUTS ≤12 MONTHS1
Open Onconic Therapeutics Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
JPI-547
NCT07364422
P1/2Not yet recruitingGastric Cancer (GC)492026-02-28
NCT07160790
NCT07160790
P3Not yet recruitingNon-erosive Gastroesophageal Reflux Disease3212026-06-30
JP-1366 10 mg
NCT06439563
P3RecruitingPeptic Ulcer3642027-08
NCT07875933
NCT07875933
P3Not yet recruitingH. Pylori Eradication Therapy4142028-09-06
JP-1366 10 mg
NCT07732075
P3Not yet recruitingMaintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD)3842028-10-30
JPI-547
NCT07370818
P2Not yet recruitingOvarian Cancer812029-12-31
JPI-547
NCT05257993
P1/2RecruitingPancreatic Ductal Adenocarcinoma712030-04 (+80 mo)